Most Popular White Papers
Manufacturing Industry
Melbourne-based Prana reported successful Phase IIa results for its second generation 8-OH quinolone
Chemistry and Industry, Sept 8, 2008
Melbourne-based Prana reported successful Phase IIa results for its second generation 8-OH quinolone, which blocks the interaction between amyloid proteins and naturally occurring metal ions in the brain known to trigger beta amyloid deposition.
COPYRIGHT 2008 Society of Chemical Industry
COPYRIGHT 2008 Gale, Cengage Learning